2 papers
cs.AI2026
Do AI-Native Biotechs Need Departments? Benchmarking Company World Models for AI-Driven Drug Development
Yinan Wang
AI-native biotechnology companies are often designed by copying human biotech org charts into agent roles. We argue for a different abstraction: a Company World Model, defined as a…
cs.AI2026
AI Scientists Are Only as Good as Their Evidence: A Stratified Ablation of Proprietary Data and Reasoning Skills in Drug-Asset Valuation
Yinan Wang
AI Scientist agents are often evaluated as if capability were mainly a function of model quality, prompting, or reasoning scaffolds. We test a different hypothesis in drug-asset va…